Infectious Diseases II
importance of combination therapy. Clin Infect Dis.
2012;55(7):943-950. https://doi.org/10.1093/cid/cis588
van Duin D, Bonomo RA. Ceftazidime/avibactam and
ceftolozane/tazobactam: second-generation ฮฒ-lactam/
ฮฒ-lactamase inhibitor combinations. Clin Infect Dis.
2016;63(2):234-241. https://doi.org/10.1093/cid/ciw243
van Duin D, Cober ED, Richter SS, et al. Tigecycline
therapy for carbapenem-resistant Klebsiella pneumoniae
(CRKP) bacteriuria leads to tigecycline resistance. Clin
Microbiol Infect. 2014;20(12):O1117-O1120. https://doi.
org/10.1111/1469-0691.12714
van Duin D, Lok JJ, Earley M, et al. Colistin versus
ceftazidime-avibactam in the treatment of infections
due to carbapenem-resistant Enterobacteriaceae. Clin
Infect Dis. 2018;66(2):163-171. https://doi.org/10.1093/
cid/cix783
Weiner-Lastinger LM, Abner S, Edwards JR, et al.
Antimicrobial-resistant pathogens associated with adult
healthcare-associated infections: summary of data
reported to the National Healthcare Safety Network,
2015-2017. Infect Control Hosp Epidemiol. 2020;41(1):1-
18. https://doi.org/10.1017/ice.2019.296
Wu JY, Srinivas P, Pogue JM. Cefiderocol: a novel agent
for the management of multidrug-resistant gram-nega-
tive organisms. Infect Dis Ther. 2020;9(1):17-40. https://
doi.org/10.1007/s40121-020-00286-6
Wunderink RG, Giamarellos-Bourboulis EJ, Rahav G, et
al. Effect and safety of meropenem-vaborbactam versus
best-available therapy in patients with carbapenem-
resistant Enterobacteriaceae infections: the TANGO II
randomized clinical trial. Infect Dis Ther. 2018;7(4):439-
455. https://doi.org/10.1007/s40121-018-0214-1
Wunderink RG, Niederman MS, Kollef MH, et al.
Linezolid
in
methicillin-resistant
Staphylococcus
aureus nosocomial pneumonia: a randomized, con-
trolled study. Clin Infect Dis. 2012;54(5):621-629. https://
doi.org/10.1093/cid/cir895
Wunderink RG, Roquilly A, Croce M, et al. A
phase 3, randomized, double-blind study compar-
ing tedizolid phosphate and linezolid for treatment of
ventilated gram-positive hospital-acquired or ventila-
tor-associated bacterial pneumonia. Clin Infect Dis.
2021;73(3):e710-e718. https://doi.org/10.1093/cid/ciab032
Immunocompromised Patients
Baden LR, Swaminathan S, Angarone M, et al.
Prevention and treatment of cancer-related infections,
version 2.2016, NCCN clinical practice guidelines in
oncology. J Natl Compr Canc Netw. 2016;14(7):882-913.
https://doi.org/10.6004/jnccn.2016.0093
Transplant. 2017;17(4):856-879. https://doi.org/10.1111/
ajt.14208
Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical
practice guideline for the use of antimicrobial agents
in neutropenic patients with cancer: 2010 update by the
Infectious Diseases Society of America. Clin Infect Dis.
2011;52(4):e56-e93. https://doi.org/10.1093/cid/cir073
Taplitz RA, Kennedy EB, Bow EJ, et al. Outpatient man-
agement of fever and neutropenia in adults treated for
malignancy: American Society of Clinical Oncology and
Infectious Diseases Society of America clinical practice
guideline update. J Clin Oncol. 2018;36(14):1443-1453.
https://doi.org/10.1200/jco.2017.77.6211
HIV/AIDS in Critically Ill Patients
Barbier F, Mer M, Szychowiak P, et al. Management of
HIV-infected patients in the intensive care unit. Intensive
s00134-020-05945-3
Panel on Antiretroviral Guidelines for Adults and
Adolescents. Guidelines for the use of antiretrovi-
ral agents in HIV-1-infected adults and adolescents.
Department of Health and Human Services. https://clini-
calinfo.hiv.gov/sites/default/files/guidelines/documents/
adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf
Panel on Guidelines for the Prevention and Treatment
of Opportunistic Infections in Adults and Adolescents
with HIV. Guidelines for the prevention and treatment of
opportunistic infections in adults and adolescents with
HIV. National Institutes of Health, Centers for Disease
Control and Prevention, the HIV Medicine Association,
and the Infectious Diseases Society of America.
https://clinicalinfo.hiv.gov/sites/default/files/guidelines/
documents/adult-adolescent-oi/guidelines-adult-adoles-
cent-oi.pdf
Rosen MJ, Narasimhan M. Critical care of immuno-
compromised patients: human immunodeficiency virus.
org/10.1097/01.ccm.0000232491.15369.ab